Search

everythinglearnresearchcommunity

for

Search:↓

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The document's conclusion cannot be provided because the document is not readable or understandable.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Increasing XIAP and DDRGK1 can help prevent hearing loss from loud noise.

KY19382 helps to regrow hair and create new hair follicles.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Certain genetic variations are linked to hair loss in Mexican men.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Reduced cytokinin levels help plants adapt to low potassium by increasing root hair growth and potassium uptake.

Sorafenib can cause a unique skin reaction.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

Personality affects stress response more than social rank, but low rank worsens stress effects, harming health.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Fluconazole-loaded hair gel may offer a longer-lasting dandruff treatment.

Infants with severe KID syndrome may be more prone to serious infections and need close monitoring.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.